Results 181 to 190 of about 3,653,860 (344)
Egalitarian Justice and the Prevalence Principle in Human Genome Editing. [PDF]
J Med PhilosMacKay D +4 more
europepmc +1 more source
Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
Aging and Cancer, EarlyView.This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley +1 more source
When to Adjust for Multiple Testing: A Unifying Guiding Principle. [PDF]
Biom JHoffmann S +8 more
europepmc +1 more source
The Principle of Maupertuis [PDF]
Proceedings of the National Academy of Sciences, 1931 openaire +2 more sources
A Bootstrap Invariance Principle for Highly Nonstationary Long Memory Processes [PDF]
This paper presents an invariance principle for highly nonstationary long memory processes, defined as processes with long memory parameter lying in (1, 1.5).
George Kapetanios
core
New Directions for Adult and Continuing Education, EarlyView.ABSTRACT Advancing artificial intelligence (AI) has transformed learning and work, yet higher education and professional development programs have not systematically equipped learners for AI‐prevalent environments. This lack of preparation creates uncertainty regarding control, responsibility, trust, and accountability.
Moon‐Heum Cho, Jerusalem Merkebu
wiley +1 more source
Hankel's principle as an anti-Kantian program. [PDF]
Arch Hist Exact SciToader ID.
europepmc +1 more source
European Accents of the Non bis in idem Principle [PDF]
The principle of non bis in idem is a classic principle of law under his person may be convicted twice for committing the same acts. When the offense is committed within the jurisdiction of one country, follow the principle set out is easy.
Gorunescu, Mirela
core
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Annals of Clinical and Translational Neurology, EarlyView.Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source